Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00592865 · ClinicalTrials.gov registry record

Risk Factors for Adult-Onset Brain Tumors

A clinical trial, sponsored by Vanderbilt University Medical Center.

Terminated
Registry status
850
Enrollment target

NCT00592865: Clinical Trial study, sponsored by Vanderbilt University Medical Center.

NCT00592865 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 850 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00592865 was terminated before completion, sponsored by Vanderbilt University Medical Center.

TERMINATED
Registry status
850 participants
Enrollment target

Study Summary

Study Objective: Brain tumors are poorly understood. The purpose of this research is to examine whether factors in lifestyle play a role in brain tumor development. The study will also investigate the contribution of inherited susceptibility to the risk of brain cancer. By gaining a better understanding of these influences, the investigators hope to learn how to prevent brain tumors in future generations, and to develop more effective strategies for treatment. Study Protocol: This is a case-control investigation. Persons affected with a brain tumor are compared to unaffected persons on previous medical history, diet and other factors. Those enrolled in the study will participate in an interview on general background, diet, medical history and lifestyle, and will provide a sample of DNA, clippings of your toenails, and a tap water sample from your home. All procedures are performed in the clinic or through the mail. 'Cases': Cases eligible for the study are persons with a recent diagnosis of a primary brain tumor (glioma or meningioma), at least 18 years of age. 'Controls': Controls in the study are non-family members of patients, similar in age and of the same gender. Suitable controls include in-laws, friends, neighbors and co-workers.

Trial Details

FieldValue
Enrollment Target 850 participants
Start Date 2003-10
Est. Completion 2015-01

Why NCT00592865 stopped before completion

NCT00592865 is an observational study that tracks outcomes without assigning an intervention. The registered 850 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00592865 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00592865 about?

NCT00592865 is a clinical study titled "Risk Factors for Adult-Onset Brain Tumors". Study Objective: Brain tumors are poorly understood. The purpose of this research is to examine whether factors in lifestyle play a role in brain tumor development. The study will also investigate the contribution of inherited susceptibility to the risk of brain cancer. By gaining a better understa...

What is the current status of trial NCT00592865?

This trial is currently terminated. The enrollment target is 850 participants. The study started on 2003-10. Estimated completion is 2015-01.

Who is sponsoring clinical trial NCT00592865?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03507257 · 850 participants

    Longitudinal Early-onset Alzheimer's Disease Study Protocol

  • NCT05846841 · 850 participants · NA

    Personalized Tobacco Treatment in Primary Care (MOTIVATE)

  • NCT05987059 · 850 participants · Phase 2

    Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT

  • NCT06289673 · 850 participants · Phase 4

    Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00592865, the US trial registry maintained by the National Library of Medicine. NCT00592865 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.